---
document_datetime: 2026-02-11 13:05:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/lumark.html
document_name: lumark.html
version: success
processing_time: 0.1041236
conversion_datetime: 2026-02-13 18:35:26.945289
docling_version:
  docling-serve: 1.12.0
  docling-jobkit: 1.10.2
  docling: 2.73.1
  docling-core: 2.65.1
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Search

- [Medicines](/en/medicines)
    - [Find medicine](/en/medicines)
    - [Therapeutic areas: latest updates](/en/medicines/therapeutic-areas-latest-updates)
    - [Download medicine data](/en/medicines/download-medicine-data)
    - [What we publish on medicines and when](/en/medicines/what-we-publish-medicines-when)
    - [Medicines under evaluation](/en/medicines/medicines-human-use-under-evaluation)
    - [National registers](/en/medicines/national-registers-authorised-medicines)
- [Human regulatory](/en/human-regulatory-overview)
    - [Overview](/en/human-regulatory-overview)
    - [Research and development](/en/human-regulatory-overview/research-development)
    - [Marketing authorisation](/en/human-regulatory-overview/marketing-authorisation)
    - [Post-authorisation](/en/human-regulatory-overview/post-authorisation)
    - [Medical devices](/en/human-regulatory-overview/medical-devices)
    - [Herbal products](/en/human-regulatory-overview/herbal-medicinal-products)
- [Veterinary regulatory](/en/veterinary-regulatory-overview)
    - [Overview](/en/veterinary-regulatory-overview)
    - [Research and development](/en/veterinary-regulatory-overview/research-development-veterinary-medicines)
    - [Marketing authorisation](/en/veterinary-regulatory-overview/marketing-authorisation-veterinary-medicines)
    - [Post-authorisation](/en/veterinary-regulatory-overview/post-authorisation-veterinary-medicines)
- [Committees](/en/committees)
    - [Overview](/en/committees)
    - [How the committees work](/en/committees/how-committees-work)
    - [CHMP](/en/committees/committee-medicinal-products-human-use-chmp)
    - [CVMP](/en/committees/committee-veterinary-medicinal-products-cvmp)
    - [PRAC](/en/committees/pharmacovigilance-risk-assessment-committee-prac)
    - [COMP](/en/committees/committee-orphan-medicinal-products-comp)
    - [HMPC](/en/committees/committee-herbal-medicinal-products-hmpc)
    - [CAT](/en/committees/committee-advanced-therapies-cat)
    - [PDCO](/en/committees/paediatric-committee-pdco)
    - [Working parties and other groups](/en/committees/working-parties-other-groups)
- [News &amp; events](/en/news-events)
    - [Overview](/en/news-events)
    - [News](/en/news)
    - [Events](/en/events/upcoming-events)
    - [What's new](/en/news-events/whats-new)
    - [Committee highlights](/en/news-events/committee-highlights)
    - [Publications](/en/news-and-events/publications)
    - [Press and social media](/en/news-events/press-social-media)
    - [Podcast: Inside EMA](/en/news-events/podcast-inside-ema)
    - [Open consultations](/en/news-events/open-consultations)
    - [RSS feeds](/en/news-events/rss-feeds)
- [Partners &amp; networks](/en/partners-networks)
    - [Overview](/en/partners-networks)
    - [EU partners](/en/partners-networks/eu-partners)
    - [International activities](/en/partners-networks/international-activities)
    - [Patients and consumers](/en/partners-networks/patients-consumers)
    - [Healthcare professionals](/en/partners-networks/healthcare-professionals)
    - [Academia](/en/partners-networks/academia)
    - [Pharmaceutical industry](/en/partners-networks/pharmaceutical-industry)
    - [Networks](/en/partners-networks/networks)
    - [Health technology assessment bodies](/en/partners-networks/health-technology-assessment-bodies)
    - [One Health approach](/en/partners-networks/one-health-approach)
    - [Animal health practitioners](/en/partners-networks/animal-health-practitioners)
    - [One substance - one assessment](/en/partners-networks/one-substance-one-assessment-osoa-eu-collaboration-chemicals-related-data)
- [About us](/en/about-us)
    - [Overview](/en/about-us)
    - [What we do](/en/about-us/what-we-do)
    - [Who we are](/en/about-us/who-we-are)
    - [How we work](/en/about-us/how-we-work)
    - [Fees](/en/about-us/fees-payable-european-medicines-agency)
    - [Support to SMEs](/en/about-us/support-smes)
    - [Annual reports and work programmes](/en/about-us/annual-reports-work-programmes)
    - [History of EMA](/en/about-us/history-ema)
    - [Careers](/en/about-us/careers)
    - [Procurement](/en/about-us/procurement-grants)
    - [Glossaries](/en/about-us/glossaries)
    - [About this website](/en/about-us/about-website)
    - [Data protection and privacy](/en/about-us/data-protection-privacy-ema)
    - [Contacts](/en/about-us/contacts-european-medicines-agency)

1. [Home](/en/homepage)
2. [Medicines](https://www.ema.europa.eu/en/medicines)
3. Lumark

# Lumark

[RSS](/en/individual-human-medicine.xml/65797)

##### Withdrawn

This medicine's authorisation has been withdrawn

lutetium (177Lu) chloride Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Lumark](#news-on)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 16 January 2026, the European Commission withdrew the marketing authorisation for Lumark (lutetium ( 177 Lu) chloride) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, I.D.B. Holland B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Lumark was granted marketing authorisation in the EU on 19 June 2015 for the radiolabelling of carrier molecules. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2020. The last manufacturing of Lumark from the registered site was in December 2022. The product has not been marketed in the EU since, and there is no remaining product on the market.

Lumark (lutetium ( 177 Lu) chloride) is a radiopharmaceutical precursor used for the radiolabelling of carrier molecules. There are other medicinal products containing lutetium ( 177 Lu) chloride authorised and marketed in the EU for the radiolabelling of carrier molecules.

Lumark : EPAR - Medicine overview

Reference Number: EMA/285451/2015

English (EN) (87.34 KB - PDF)

**First published:** 16/07/2015

**Last updated:** 11/02/2026

[View](/en/documents/overview/lumark-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-112)

български (BG) (114.96 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/bg/documents/overview/lumark-epar-medicine-overview_bg.pdf)

español (ES) (86.27 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/es/documents/overview/lumark-epar-medicine-overview_es.pdf)

čeština (CS) (109.54 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/cs/documents/overview/lumark-epar-medicine-overview_cs.pdf)

dansk (DA) (86.5 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/da/documents/overview/lumark-epar-medicine-overview_da.pdf)

Deutsch (DE) (88.96 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/de/documents/overview/lumark-epar-medicine-overview_de.pdf)

eesti keel (ET) (85.73 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/et/documents/overview/lumark-epar-medicine-overview_et.pdf)

ελληνικά (EL) (123.39 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/el/documents/overview/lumark-epar-medicine-overview_el.pdf)

français (FR) (86.77 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fr/documents/overview/lumark-epar-medicine-overview_fr.pdf)

hrvatski (HR) (104.55 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hr/documents/overview/lumark-epar-medicine-overview_hr.pdf)

italiano (IT) (85.88 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/it/documents/overview/lumark-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (117.28 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lv/documents/overview/lumark-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (108.41 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lt/documents/overview/lumark-epar-medicine-overview_lt.pdf)

magyar (HU) (105.41 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hu/documents/overview/lumark-epar-medicine-overview_hu.pdf)

Malti (MT) (110.93 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/mt/documents/overview/lumark-epar-medicine-overview_mt.pdf)

Nederlands (NL) (87.69 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/nl/documents/overview/lumark-epar-medicine-overview_nl.pdf)

polski (PL) (109.79 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pl/documents/overview/lumark-epar-medicine-overview_pl.pdf)

português (PT) (88.24 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pt/documents/overview/lumark-epar-medicine-overview_pt.pdf)

română (RO) (114.67 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/ro/documents/overview/lumark-epar-medicine-overview_ro.pdf)

slovenčina (SK) (109.67 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sk/documents/overview/lumark-epar-medicine-overview_sk.pdf)

slovenščina (SL) (103.29 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sl/documents/overview/lumark-epar-medicine-overview_sl.pdf)

Suomi (FI) (85.56 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fi/documents/overview/lumark-epar-medicine-overview_fi.pdf)

svenska (SV) (86.29 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sv/documents/overview/lumark-epar-medicine-overview_sv.pdf)

Lumark : EPAR - Risk-management-plan summary

English (EN) (88.99 KB - PDF)

**First published:** 16/07/2015

**Last updated:** 11/02/2026

[View](/en/documents/rmp-summary/lumark-epar-risk-management-plan-summary_en.pdf)

## Product information

Lumark : EPAR - Product Information

English (EN) (272.16 KB - PDF)

**First published:** 16/07/2015

**Last updated:** 11/02/2026

[View](/en/documents/product-information/lumark-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-782)

български (BG) (423.47 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/bg/documents/product-information/lumark-epar-product-information_bg.pdf)

español (ES) (280.39 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/es/documents/product-information/lumark-epar-product-information_es.pdf)

čeština (CS) (296.68 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/cs/documents/product-information/lumark-epar-product-information_cs.pdf)

dansk (DA) (189.25 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/da/documents/product-information/lumark-epar-product-information_da.pdf)

Deutsch (DE) (212.45 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/de/documents/product-information/lumark-epar-product-information_de.pdf)

eesti keel (ET) (187.79 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/et/documents/product-information/lumark-epar-product-information_et.pdf)

ελληνικά (EL) (355.53 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/el/documents/product-information/lumark-epar-product-information_el.pdf)

français (FR) (194.57 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fr/documents/product-information/lumark-epar-product-information_fr.pdf)

hrvatski (HR) (274.9 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hr/documents/product-information/lumark-epar-product-information_hr.pdf)

íslenska (IS) (271.38 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/is/documents/product-information/lumark-epar-product-information_is.pdf)

italiano (IT) (304.81 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/it/documents/product-information/lumark-epar-product-information_it.pdf)

latviešu valoda (LV) (381.91 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lv/documents/product-information/lumark-epar-product-information_lv.pdf)

lietuvių kalba (LT) (391.46 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lt/documents/product-information/lumark-epar-product-information_lt.pdf)

magyar (HU) (295.52 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hu/documents/product-information/lumark-epar-product-information_hu.pdf)

Malti (MT) (382.31 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/mt/documents/product-information/lumark-epar-product-information_mt.pdf)

Nederlands (NL) (190.79 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/nl/documents/product-information/lumark-epar-product-information_nl.pdf)

norsk (NO) (275.38 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/no/documents/product-information/lumark-epar-product-information_no.pdf)

polski (PL) (396.52 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pl/documents/product-information/lumark-epar-product-information_pl.pdf)

português (PT) (272.31 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pt/documents/product-information/lumark-epar-product-information_pt.pdf)

română (RO) (299.91 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/ro/documents/product-information/lumark-epar-product-information_ro.pdf)

slovenčina (SK) (285.97 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sk/documents/product-information/lumark-epar-product-information_sk.pdf)

slovenščina (SL) (358.48 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sl/documents/product-information/lumark-epar-product-information_sl.pdf)

Suomi (FI) (215.29 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fi/documents/product-information/lumark-epar-product-information_fi.pdf)

svenska (SV) (197.34 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sv/documents/product-information/lumark-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** PSUSA/00010391/201912 17/09/2020

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Lumark : EPAR - All Authorised presentations

English (EN) (32.43 KB - PDF)

**First published:** 16/07/2015

**Last updated:** 11/02/2026

[View](/en/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-50)

български (BG) (55.31 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/bg/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_bg.pdf)

español (ES) (31.13 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/es/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_es.pdf)

čeština (CS) (47.84 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/cs/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (31.48 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/da/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (31.1 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/de/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (31.33 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/et/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (53.65 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/el/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_el.pdf)

français (FR) (53.6 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fr/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (47.01 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hr/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (30.71 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/is/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_is.pdf)

italiano (IT) (31.04 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/it/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (47.65 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lv/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (61.86 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/lt/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (37.99 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/hu/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (48.93 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/mt/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (31.17 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/nl/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (30.58 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/no/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_no.pdf)

polski (PL) (47.73 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pl/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_pl.pdf)

português (PT) (31.3 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/pt/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_pt.pdf)

română (RO) (47.94 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/ro/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (47.66 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sk/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (38.13 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sl/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (53.56 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/fi/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (31.12 KB - PDF)

**First published:**

16/07/2015

**Last updated:**

11/02/2026

[View](/sv/documents/all-authorised-presentations/lumark-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Lumark Active substance lutetium (177Lu) chloride International non-proprietary name (INN) or common name lutetium (177Lu) chloride Therapeutic area (MeSH) Radionuclide Imaging Anatomical therapeutic chemical (ATC) code V10

### Pharmacotherapeutic group

Therapeutic radiopharmaceuticals

### Therapeutic indication

Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.

## Authorisation details

EMA product number EMEA/H/C/002749 Marketing authorisation holder

I.D.B. Radiopharmacy B.V.

I.D.B. Holland B.V.

Opinion adopted 22/04/2015 Marketing authorisation issued 18/06/2015 Withdrawal of marketing authorisation 16/01/2026 Revision 9

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Lumark : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (165.33 KB - PDF)

**First published:** 07/09/2016

**Last updated:** 11/02/2026

[View](/en/documents/procedural-steps-after/lumark-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201912 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/509367/2020

English (EN) (136.47 KB - PDF)

**First published:** 29/09/2020

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201912-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201812 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/449645/2019

English (EN) (127.73 KB - PDF)

**First published:** 01/10/2019

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201812-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201806 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/199298/2019

English (EN) (127.97 KB - PDF)

**First published:** 05/04/2019

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201806-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201712 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/895480/2018

English (EN) (87.58 KB - PDF)

**First published:** 14/01/2019

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201712-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201706 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/207706/2018

English (EN) (82.52 KB - PDF)

**First published:** 09/04/2018

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201706-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

Lumark-H-C-PSUSA-00010391-201612 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/686367/2017

English (EN) (91.33 KB - PDF)

**First published:** 17/10/2017

**Last updated:** 11/02/2026

[View](/en/documents/scientific-conclusion/lumark-h-c-psusa-00010391-201612-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Lumark : EPAR - Public assessment report

Adopted

Reference Number: EMA/427491/2015

English (EN) (1.74 MB - PDF)

**First published:** 16/07/2015

**Last updated:** 11/02/2026

[View](/en/documents/assessment-report/lumark-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Lumark

Adopted

Reference Number: EMA/247591/2015

English (EN) (93.91 KB - PDF)

**First published:** 24/04/2015

**Last updated:** 11/02/2026

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-lumark_en.pdf)

#### News on Lumark

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 April 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-april-2015) 24/04/2015

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 11/02/2026

## Share this page

[Back to top](#main-content)